Gene expression by PBMC in primary sclerosing cholangitis: Evidence for dysregulation of immune mediated genes

Clinical and Developmental Immunology

Volumn 13, Issue 2-4, 2006, Pages 265-271

  Aoki, Christopher A ^a   Dawson, Kevin ^a   Kenny, Thomas P ^b   Gershwin, M Eric ^b   Bowlus, Christopher L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Division of Rheumatology Allergy and Clinical Immunology   (United States)

Author keywords

Membrane spanning 4 domains subfamily A (ms4a); Microarray; Similar to mothers against decapentaplegic homolog 5 (SMAD 5); TNF induced protein 6 (TNFaip6)

Indexed keywords

INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEIN MS4A; SMAD5 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 6;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; IMMUNOGENETICS; MALE; MICROARRAY ANALYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA ISOLATION; STATISTICAL ANALYSIS;

ADULT; CHOLANGITIS, SCLEROSING; FEMALE; GENE EXPRESSION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED;

EID: 33845679713     PISSN: 17402522     EISSN: 10292357     Source Type: Journal    
DOI: 10.1080/17402520600800085     Document Type: Article

References (39)

1. Adra CN, Lelias JM, Kobayashi H, Kaghad M, Morrison P, Rowley JD, Lim B. 1994. Cloning of the cDNA for a hematopoietic cell-specific protein related to CD20 and the beta subunit of the high-affinity IgE receptor: Evidence for a family of proteins with four membrane-spanning regions. Proc Natl Acad Sci USA 91(21):10178-10182.
2. Adra CN, Mao XQ, Kawada H, Gao PS, Korzycka B, Donate JL, Shaldon SR, Coull P, Dubowitz M, Enomoto T, et al. 1999. Chromosome 11q13 and atopic asthma. Clin Genet 55(6):431-437.
3. Aoki CA, Borchers AT, Li M, Flavell RA, Bowlus CL, Ansari AA, Gershwin ME. 2005a. Transforming growth factor beta (TGF-beta) and autoimmunity. Autoimmun Rev 4(7):450-459.
4. Aoki CA, Bowlus CL, Gershwin ME. 2005b. The immunobiology of primary sclerosing cholangitis. Autoimmun Rev 4(3):137-143.
5. Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, Loftus EV, Jr, Yawn BP, Dickson ER, Melton LJ, 3rd. 2003. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 125(5):1364-1369.
6. Bergquist A, Lindberg G, Saarinen S, Broome U. 2005. Increased prevalence of primary sclerosing cholangitis among first-degree relatives. J Hepatol 42(2):252-256.
7. Bittencourt PL, Palacios SA, Cancado EL, Carrilho FJ, Porta G, Kalil J, Goldberg AC. 2002. Susceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1*13 but not with tumour necrosis factor alpha -308 promoter polymorphism. Gut 51(4):609-610.
8. Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, Sherlock S. 1980. Primary sclerosing cholangitis: A review of its clinical features, cholangiography, and hepatic histology. Gut 21(10):870-877.
9. Chapman RW, Varghese Z, Gaul R, Patel G, Kokinon N, Sherlock S. 1983. Association of primary sclerosing cholangitis with HLAB8. Gut 24(1):38-41.
10. Djeu JY, Liu JH, Wei S, Rui H, Pearson CA, Leonard WJ, Blanchard DK. 1993. Function associated with IL-2 receptor-beta on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2. J Immunol 150(3):960-970.
11. Donaldson PT, Norris S. 2001. Immunogenetics in PSC. Best Pract Res Clin Gastroenterol 15(4):611-627.
12. Espinoza-Delgado I, Ortaldo JR, Winkler-Pickett R, Sugamura K, Varesio L, Longo DL. 1990. Expression and role of p75 interleukin 2 receptor on human monocytes. J Exp Med 171(5):1821-1826.
13. Hahm KB, Im YH, Parks TW, Park SH, Markowitz S, Jung HY, Green J, Kim SJ. 2001. Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut 49(2):190-198.
14. Hupp K, Siwarski D, Mock BA, Kinet JP. 1989. Gene mapping of the three subunits of the high affinity FcR for IgE to mouse chromosomes 1 and 19. J Immunol 143(11):3787-3791.
15. Ishibashi K, Suzuki M, Sasaki S, Imai M. 2001. Identification of a new multigene four-transmembrane family (MS4A) related to CD20, HTm4 and beta subunit of the high-affinity IgE receptor. Gene 264(1):87-93.
16. Lee TH, Wisniewski HG, Vilcek J. 1992. A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44. J Cell Biol 116(2):545-557.
17. Lee TH, Klampfer L, Shows TB, Vilcek J. 1993. Transcriptional regulation of TSG6, a tumor necrosis factor- and interleukin-1-inducible primary response gene coding for a secreted hyaluronan-binding protein. J Biol Chem 268(9):6154-6160.
18. Leonard WJ, Depper JM, Crabtree GR, Rudikoff S, Pumphrey J, Robb RJ, Kronke M, Svetlik PB, Peffer NJ, Waldmann TA, et al. 1984. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 311(5987):626-631.
19. Liang Y, Tedder TF. 2001. Identification of a CD20-, FcepsilonRI-beta-, and HTm4-related gene family: Sixteen new MS4A family members expressed in human and mouse. Genomics 72(2):119-127.
20. Lindor KD, Wiesner RH, Katzmann JA, LaRusso NF, Beaver SJ. 1987. Lymphocyte subsets in primary sclerosing cholangitis. Dig Dis Sci 32(7):720-725.
21. Milner CM, Day AJ. 2003. TSG-6: A multifunctional protein associated with inflammation. J Cell Sci 116(Pt 10): 1863-1873.
22. Neri TM, Cavestro GM, Seghini P, Zanelli PF, Zanetti A, Savi M, Podda M, Zuin M, Colombo M. Floreani A, et al. 2003. Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population. Dig Liver Dis 35(8):571-576.
23. Nishikawa K, Saito S, Morii T, Kato Y, Narita N, Ichijo M, Ohashi Y, Takeshita T, Sugamura K. 1990. Differential expression of the interleukin 2 receptor beta (p75) chain on human peripheral blood natural killer subsets. Int Immunol 2(6):481-486.
24. Saarinen S, Olerup O, Broome U. 2000. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am J Gastroenterol 95(11):3195-3199.
25. Schrumpf E, Fausa O, Forre O, Dobloug JH, Ritland S, Thorsby E. 1982. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol 17(2):187-191.
26. Schrumpf E, Boberg KM. 2001. Epidemiology of primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 15(4):553-562.
27. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW. 2001. Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut 49(4):565-576.
28. Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome U, Caballeria L, Ciusani E, Chapman R, Ercilla G, Fausa O, et al. 1999. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens 53(5):459-469.
29. Suzuki H, Kundig TM, Furlonger C, Wakeham A, Timms E, Matsuyama T, Schmits R, Simard JJ, Ohashi PS, Griesser H, et al. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268(5216):1472-1476.
30. Tanaka T, Takeuchi Y, Shiohara T, Kitamura F, Nagasaka Y, Hamamura K, Yagita H, Miyasaka M. 1992. In utero treatment with monoclonal antibody to IL-2 receptor beta-chain completely abrogates development of Thy-1 + dendritic epidermal cells. Int Immunol 4(4):487-491.
31. Tedder TF, Klejman G, Disteche CM, Adler DA, Schlossman SF, Saito H. 1988. Cloning of a complementary DNA encoding a new mouse B lymphocyte differentiation antigen, homologous to the human B1 (CD20) antigen, and localization of the gene to chromosome 19. J Immunol 141(12):4388-4394.
32. Terjung B, Worman HJ. 2001. Anti-neutrophil antibodies in primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 15(4):629-642.
33. Wiencke K, Spurkland A, Schrumpf E, Boberg KM. 2001. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles. Hepatology 34(4 Pt 1):625-630.
34. Wiesner RH, LaRusso NF. 1980. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 79(2):200-206.
35. Wisniewski HG, Maier R, Lotz M, Lee S, Klampfer L, Lee TH, Vilcek J. 1993. TSG-6: A TNF-, IL-1-, and LPS-inducible secreted glycoprotein associated with arthritis. J Immunol 151(11):6593-6601.
36. Wisniewski HG, Burgess WH, Oppenheim JD, Vilcek J. 1994. TSG-6, an arthritis-associated hyaluronan binding protein, forms a stable complex with the serum protein inter-alpha-inhibitor. Biochemistry 33(23):7423-7429.
37. Wisniewski HG, Hua JC, Poppers DM, Naime D, Vilcek J, Cronstein BN. 1996. TNF/IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-alpha-inhibitor and exerts a strong anti-inflammatory effect in vivo. J Immunol 156(4):1609-1615.
38. Wisniewski HG, Vilcek J. 1997. TSG-6: An IL-1/TNF-inducible protein with anti-inflammatory activity. Cytokine Growth Factor Rev 8(2):143-156.
39. Zola H, Weedon H, Thompson GR, Fung MC, Ingley E, Hapel AJ. 1991. Expression of IL-2 receptor p55 and p75 chains by human B lymphocytes: Effects of activation and differentiation. Immunology 72(2):167-173.